Macrocyclic Inhibitors of the NS3 Protease as Potential Therapeutic Agents of Hepatitis C Virus InfectionYoula S. Tsantrizos, Daniel Lamarre, Nathalie Goudreau et al.|Angewandte Chemie International Edition|2003Cited by 188
Ligand Bioactive Conformation Plays a Critical Role in the Design of Drugs That Target the Hepatitis C Virus NS3 ProteaseSteven R. LaPlante, Stephen H. Kawai, Herbert Nar et al.|Journal of Medicinal Chemistry|2013Cited by 49
.alpha.-Cobratoxin: proton NMR assignment and solution structureRemi Le Goas, Jean Yves Lallemand, Steven R. LaPlante et al.|Biochemistry|1992Cited by 45
Macrocyclic Inhibitors of the NS3 Protease as Potential Therapeutic Agents of Hepatitis C Virus InfectionYoula S. Tsantrizos, Daniel Lamarre, Gordon T. Bolger et al.|Angewandte Chemie|2003Cited by 31
Design and Synthesis of Macrocyclic Inhibitors of the Hepatitis C NS3 ProteaseMartin Poirier, Youla S. Tsantrizos, Murray D. Bailey et al.|Elsevier eBooks|2003Cited by 0